New Ray Medicine International Holding (HKSE:06108) PEG Ratio: N/A (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06108 New Ray Medicine International Holding Ltd HKSE:06108
52 GF Score
Price HK$0.21
GF Value HK$1.04
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is New Ray Medicine International Holding PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, New Ray Medicine International Holding's PE Ratio without NRI is 0.00. New Ray Medicine International Holding's 5-Year EBITDA growth rate is 0.00%. Therefore, New Ray Medicine International Holding's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for New Ray Medicine International Holding's PEG Ratio or its related term are showing as below:



HKSE:06108's PEG Ratio is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.475
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

New Ray Medicine International Holding  (HKSE:06108) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

New Ray Medicine International Holding PEG Ratio Related Terms

New Ray Medicine International Holding PEG Ratio Historical Data

* Premium members only.

The historical data trend for New Ray Medicine International Holding's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Ray Medicine International Holding PEG Ratio Chart

New Ray Medicine International Holding Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

New Ray Medicine International Holding Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

New Ray Medicine International Holding PEG Ratio Competitor Comparison

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Ray Medicine International Holding PEG Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's PEG Ratio distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's PEG Ratio falls into.


HKSE:06108
52GF Score
New Ray Medicine International Holding Ltd HKSE:06108
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Ray Medicine International Holding PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

New Ray Medicine International Holding's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is New Ray Medicine International Holding (HKSE:06108) Overvalued in 2026?

Based on GuruFocus' analysis, New Ray Medicine International Holding stock appears to be undervalued. The current stock price of HK$0.21 is trading 79.9% below its estimated GF Value™ of HK$1.04. GuruFocus considers New Ray Medicine International Holding to be Possible Value Trap.

Key valuation signals for HKSE:06108:

  • PEG Ratio: N/A
  • GF Value™: HK$1.04 vs. price of HK$0.21 (79.9% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New Ray Medicine International Holding Business Description

Address 19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading and distribution of pharmaceutical products in the People's Republic of China. The company's segments include the Distribution and trading of pharmaceutical products and the Provision of marketing and promotion services. Distribution and trading of pharmaceutical products segment consist of Injection drugs and generate maximum revenue for the company.
52GF Score

Get the complete analysis for HKSE:06108

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.21
Price
HK$1.04
GF Value